Gen-Probe Considers Resubmitting 510(k) After FDA Denies Tigris System
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe says it will likely re-file a 510(k) for the Procleix Tigris system for use with Chiron's Ultrio assay after the FDA found it "not substantially equivalent" to previously cleared blood screening technology